These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 39217404)

  • 1. Cellular senescence and SASP in tumor progression and therapeutic opportunities.
    Dong Z; Luo Y; Yuan Z; Tian Y; Jin T; Xu F
    Mol Cancer; 2024 Aug; 23(1):181. PubMed ID: 39217404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
    Du M; Sun L; Guo J; Lv H
    Pharmacol Res; 2024 Jun; 204():107198. PubMed ID: 38692466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy.
    Jiang B; Zhang W; Zhang X; Sun Y
    Semin Cancer Biol; 2024 Jun; 101():58-73. PubMed ID: 38810814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescent tumor cells: an overlooked adversary in the battle against cancer.
    Park SS; Choi YW; Kim JH; Kim HS; Park TJ
    Exp Mol Med; 2021 Dec; 53(12):1834-1841. PubMed ID: 34916607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.
    Xiong J; Dong L; Lv Q; Yin Y; Zhao J; Ke Y; Wang S; Zhang W; Wu M
    Clin Transl Med; 2024 Sep; 14(9):e1772. PubMed ID: 39270064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-Induced Senescence: Novel Approaches for Markers Identification.
    Pacifico F; Magni F; Leonardi A; Crescenzi E
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases.
    Watanabe S; Kawamoto S; Ohtani N; Hara E
    Cancer Sci; 2017 Apr; 108(4):563-569. PubMed ID: 28165648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence-associated secretory phenotype (SASP) and uterine fibroids: Association with PD-L1 activation and collagen deposition.
    Saad EE; Michel R; Borahay MA
    Ageing Res Rev; 2024 Jun; 97():102314. PubMed ID: 38670462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Senescence: The Sought or the Unwanted?
    Sun Y; Coppé JP; Lam EW
    Trends Mol Med; 2018 Oct; 24(10):871-885. PubMed ID: 30153969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Senescence as a Brake or Accelerator for Oncogenic Transformation and Role in Lymphatic Metastasis.
    Banerjee P; Gaddam N; Pandita TK; Chakraborty S
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
    Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
    J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of flavonoids to mitigate cellular senescence in cardiovascular disease.
    Zheng H; Li T; Hu Z; Zheng Q; Wang J
    Biogerontology; 2024 Nov; 25(6):985-1010. PubMed ID: 39325277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosenescence and macrophages: From basics to therapeutics.
    Zhu H; Shen F; Liao T; Qian H; Liu Y
    Int J Biochem Cell Biol; 2023 Dec; 165():106479. PubMed ID: 37866656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.